| Decreased expression of the GABAA receptor in fragile X syndrome C d'Hulst, N De Geest, SP Reeve, D Van Dam, PP De Deyn, BA Hassan, ... Brain research 1121 (1), 238-245, 2006 | 362 | 2006 |
| The complexity of the GABAA receptor shapes unique pharmacological profiles C D’Hulst, JR Atack, RF Kooy Drug discovery today 14 (17-18), 866-875, 2009 | 227 | 2009 |
| Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS) C d'Hulst, I Heulens, JR Brouwer, R Willemsen, N De Geest, SP Reeve, ... Brain research 1253, 176-183, 2009 | 197 | 2009 |
| The GABAA receptor: a novel target for treatment of fragile X? C D’Hulst, RF Kooy Trends in neurosciences 30 (8), 425-431, 2007 | 197 | 2007 |
| Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model I Heulens, C D’Hulst, D Van Dam, PP De Deyn, RF Kooy Behavioural brain research 229 (1), 244-249, 2012 | 144 | 2012 |
| Fragile X syndrome: from molecular genetics to therapy C d’Hulst, RF Kooy Journal of medical genetics 46 (9), 577-584, 2009 | 111 | 2009 |
| The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome S Braat, C d'Hulst, I Heulens, S De Rubeis, E Mientjes, DL Nelson, ... Cell Cycle 14 (18), 2985-2995, 2015 | 87 | 2015 |
| Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients C D’Hulst, I Heulens, N Van der Aa, K Goffin, M Koole, K Porke, ... PloS one 10 (7), e0131486, 2015 | 49 | 2015 |
| Immunization with the binding domain of FimH, the adhesin of type 1 fimbriae, does not protect chickens against avian pathogenic Escherichia coli F Vandemaele, C Ververken, N Bleyen, J Geys, C D'Hulst, T Addwebi, ... Avian Pathology 34 (3), 264-272, 2005 | 38 | 2005 |
| MouSensor: a versatile genetic platform to create super sniffer mice for studying human odor coding C D’Hulst, RB Mina, Z Gershon, S Jamet, A Cerullo, D Tomoiaga, L Bai, ... Cell reports 16 (4), 1115-1125, 2016 | 32 | 2016 |
| Involvement and therapeutic potential of the GABAergic system in the fragile X syndrome I Heulens, C D′ Hulst, S Braat, L Rooms, RF Kooy The Scientific World Journal 10 (1), 2198-2206, 2010 | 27 | 2010 |
| Fast quantitative real-time PCR-based screening for common chromosomal aneuploidies in mouse embryonic stem cells C D’Hulst, I Parvanova, D Tomoiaga, ML Sapar, P Feinstein Stem Cell Reports 1 (4), 350-359, 2013 | 23 | 2013 |
| In Vitro Mutational and Bioinformatics Analysis of the M71 Odorant Receptor and Its Superfamily J Bubnell, S Jamet, D Tomoiaga, C D’Hulst, K Krampis, P Feinstein PLoS One 10 (10), e0141712, 2015 | 15 | 2015 |
| The GABAA receptor as a potential target for therapy of the fragile X syndrome F Kooy, I Heulens, C D’Hulst, N Van der Aa, C Bagni, B Hassan, ... NFXF 12th International FX Conference; July 21-25; Detroit, MI, 2010 | 9 | 2010 |
| A genetic platform for functionally profiling odorant receptors in olfactory cilia ex vivo M Omura, Y Takabatake, E Lempert, S Benjamin-Hong, C D’Hulst, ... Science Signaling 15 (746), eabm6112, 2022 | 3 | 2022 |
| Investigating the Mechanisms of Singularity of Odorant Receptor Gene Choice R Mina, C D'Hulst, P Feinstein Chemical Senses 43 (3), E16-E17, 2018 | 2 | 2018 |
| A Genetic Platform for Functionally Profiling Odorant Receptors Ex Vivo Using Olfactory Cilia M Omura, Y Takabatake, S Benjamin-Hong, C D’Hulst, P Feinstein bioRxiv, 2021.09. 28.462154, 2021 | 1 | 2021 |
| Biosensors for detecting changes in the level of a neurotransmitter in the central nervous system P Feinstein, C D'hulst, E Giets, M Omura, C Lemetre US Patent App. 18/245,992, 2023 | | 2023 |
| Commonality of Odorant Receptor Choice Mechanism Revealed by Analysis of a Highly Represented Odorant Receptor Transgene M Makhlouf, C D’Hulst, M Omura, A Rosa, R Mina, S Bernal-Garcia, ... bioRxiv, 2022.05. 05.489571, 2022 | | 2022 |
| Biosensor exhibiting sensitivity to trinitrotoluene P Feinstein, C D'hulst US Patent 11,255,830, 2022 | | 2022 |
